Eko Analysis Software vs vascuCAP
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Eko Analysis Software focuses on early detection of heart murmurs and atrial fibrillation through auscultation and ECG analysis, ideal for screening and remote monitoring. In contrast, vascuCAP provides detailed, histologically-validated quantification of plaque composition from CT angiograms to assess cardiovascular risk and guide treatment decisions. They address different stages of cardiovascular care with distinct data inputs and analytical approaches.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app to analyze heart sounds and ECGs. In contrast, vascuCAP (ElucidVivo/PlaqueIQ) is designed for non-invasive CT angiography analysis.
Eko Analysis Software assists in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, providing detection of normal sinus rhythm and cardiac time intervals. vascuCAP quantifies plaque composition (e.g., lipid-rich necrotic core, calcification) and assesses cardiovascular risk to optimize treatment decisions for stroke and heart attack.
Eko Analysis Software is relevant for Cardiology, Emergency Medicine, and Internal Medicine. vascuCAP is primarily aimed at Cardiology, Radiology, and Vascular Surgery specialties.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, offering secure cloud-based storage of recordings. vascuCAP features DICOM integration and PACS/EMR interoperability for seamless workflow integration.